Home > Analytics > AUROBINDO PHARMA

AUROBINDO PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 524804     NSE : AUROPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Oct 11,2024
Price(EOD): ₹ 1,495.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 86,852.83 Cr
Value of ₹ 1 Lac invested in AUROBINDO PHARMA
on Oct 11,2019 (price: ₹ 438.10)

₹ 1 L

₹ 3.41 L

1W : 2% 1M : -0.8% 1Y : 60.9%
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
AUROBINDO PHARMA 2% -0.8% 60.9%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 3% 68%
CIPLA -1.8% -2% 39.6%
DR REDDYS LABORATORIES -0.1% -0.2% 19.8%
ZYDUS LIFESCIENCES 1.4% -4.2% 76%
DIVIS LABORATORIES 13.7% 12.9% 60.4%

FUNDAMENTAL ANALYSIS OF AUROBINDO PHARMA

 
Fundamentals Score
[ Q(TTM): Jun2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AUROBINDO PHARMA

 
Valuation Score
[As on : Oct 11,2024 ]

Ratio Consolidated
P/E
P/B
P/S
24.58
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3,533.22 Cr
[Latest Qtr - Jun2024 - Consolidated Results ]

2.91
P/B Calculated based on Book Value of Rs 29,842.80 Cr
[Latest Year - Mar2024 - Consolidated Results ]

2.92
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 29,718.40 Cr
[Latest Qtr - Jun2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF AUROBINDO PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
116%
19%
35%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AUROBINDO PHARMA



AUROBINDO PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AUROBINDO PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.14
0.23
0.11
0.16
0.21
0.18
0.1
0.16
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AUROBINDO PHARMA

Pledged Promoter Shares
18.9 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AUROBINDO PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-0.17%
-3.18%
6.66%
-0.04%
10.46%
40.66%
62.64%
60.63%
QtrlyTrend
2
Latest Qtr: Jun2024
Quarterly Result Analysis →


AUROBINDO PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 2% 1.4% 58.4%
S&P BSE MIDCAP SELECT INDEX 1.6% 0.4% 53.6%
S&P BSE MIDSMALLCAP 1.1% -0.1% 50.3%
S&P BSE MID CAP 1.1% -0.4% 51%
S&P BSE 400 MIDSMALLCAP 1% -0.3% 48%
NSE Indices1W1M1Y
NIFTY PHARMA 2.1% 1.4% 55.9%
NIFTY HEALTHCARE 2% 1.8% 55.4%
NIFTY FREE MIDCAP 100 1.3% 0.3% 47%
NIFTY MIDCAP150 1.2% 0.6% 45.9%
NIFTY MID SMALL400 1.2% 0% 46.6%

You may also like the below Video Courses


FAQ about AUROBINDO PHARMA


Is AUROBINDO PHARMA good for long term investment?

As on Oct 11,2024, the Fundamentals of AUROBINDO PHARMA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AUROBINDO PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AUROBINDO PHARMA UnderValued or OverValued?

As on Oct 11,2024, AUROBINDO PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AUROBINDO PHARMA ?

As on Oct 11,2024, the Intrinsic Value of AUROBINDO PHARMA is Rs. 1,109.57 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 693.04
Fair Value [Median EV / Sales Model] : Rs. 1,257.42
Fair Value [Median Price / Sales Model] : Rs. 1,109.57
Estimated Median Fair Value of AUROBINDO PHARMA : Rs. 1,109.57

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AUROBINDO PHARMA trading at a Premium or Discount?

As on Oct 11,2024, AUROBINDO PHARMA is trading at a Premium of 35% based on the estimates of Median Intrinsic Value!